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Chromatin structure and function is regulated by reader proteins recognizing histone mod-
ifications and/or histone variants. We recently identified that PWWP2A tightly binds to H2A.
Z-containing nucleosomes and is involved in mitotic progression and cranial–facial devel-
opment. Here, using in vitro assays, we show that distinct domains of PWWP2A mediate
binding to free linker DNA as well as H3K36me3 nucleosomes. In vivo, PWWP2A strongly
recognizes H2A.Z-containing regulatory regions and weakly binds H3K36me3-containing
gene bodies. Further, PWWP2A binds to an MTA1-specific subcomplex of the NuRD complex
(M1HR), which consists solely of MTA1, HDAC1, and RBBP4/7, and excludes CHD, GATAD2
and MBD proteins. Depletion of PWWP2A leads to an increase of acetylation levels on
H3K27 as well as H2A.Z, presumably by impaired chromatin recruitment of M1HR. Thus, this
study identifies PWWP2A as a complex chromatin-binding protein that serves to direct the
deacetylase complex M1HR to H2A.Z-containing chromatin, thereby promoting changes in
histone acetylation levels.
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In 2000, the so-called “histone code hypothesis” was proposed
1,
bringing forward the concept that histone posttranslational
modifications (PTMs) can be recognized by chromatin-
modifying proteins through the action of “reader domains” that
recognize specific histone PTMs. Such recognition events lead to
the recruitment of proteins or protein complexes with enzymatic
activity, which then act to alter the surrounding chromatin
structure and consequently either promote or repress transcrip-
tion of the associated gene(s). Furthermore, histone variants,
which are deposited into chromatin through enzyme-catalyzed
exchange with their canonical counterparts2, have been found to
codetermine specificity of coregulator binding, in this way con-
tributing to the combinatorics of chromatin recognition.
Genome-wide, distinct chromatin states are defined by their
specific histone mark pattern, and these patterns have been
shown to modulate transcriptional output. For example, the
presence of acetylation on either H3 lysine 27 (H3K27) or the
histone variant H2A.Z correlates with regions identified as reg-
ulatory enhancers3. Unmodified H2A.Z is enriched at the tran-
scriptional start site (TSS), where it is thought to promote
transcription of the associated gene4. H3K36me3 is present at
active genes towards the 3′-end and is likewise involved in
transcriptional regulation5. The dynamic interplay of chromatin
states is established and controlled in part by protein complexes
such as the nucleosome remodeling and deacetylase complex
(NuRD), which typically combines both chromatin remodeling
and histone deacetylase activities6. The canonical NuRD complex
comprises at least six different proteins: HDAC1 and/or HDAC2
which mediate histone deacetylase (HDAC) activity; CHD3
or CHD4, which remodel nucleosomes in an ATP-dependent
manner; MTA1–MTA3; MBD2/MBD3; RBBP4/RBBP7; and
GATAD2A/GATAD2B. Interestingly, different combinations of
the NuRD subunits are able to form mutually exclusive NuRD
subcomplexes7–9. First described as a transcriptional silencer,
emerging evidence attributes a broader functional spectrum to the
NuRD complex including transcriptional activation or balancing
transcriptional output10,11.
Recently, we identified the vertebrate-specific PWWP2A as a
chromatin-binding transcriptional regulator that mediates proper
mitosis-progression in human cell lines and correct cranial–facial
development in the frog via a yet unknown mechanism12.
PWWP2A contains two N-terminal proline-rich regions (P1 and
P2) connected through an unique internal region (I) to a serine-
rich stretch (S) and a C-terminal PWWP domain (PWWP).
Strong chromatin interaction of PWWP2A is achieved through
binding to nucleosomes in general via the N-terminal part of the
internal stretch (IN), whereas the C-terminal internal region (IC)
mediates specificity for H2A.Z-containing nucleosomes. In
addition, the conserved PWWP domain is able to bind DNA with
relatively low affinity12.
Using quantitative in vitro binding assays, here we show that
PWWP2A is able to directly interact with at least five different
chromatin moieties with its distinct domains. Besides strong
binding to H2A.Z and the TSS of highly transcribed genes via its
IC region12, IN directly interacts with linker DNA, a combination
of S and PWWP domains mediates binding to H3K36me3 as
well as nucleic acids in vitro and promotes weak association
with H3K36me3-containing gene bodies in vivo. Additionally,
PWWP2A is also enriched at H2A.Z-containing regulatory
regions marked by high levels of both H3K27ac and H2A.Zac.
Quantitative mass spectrometry (MS) and biochemical char-
acterization identifies a robust interaction between PWWP2A
and a subcomplex of NuRD comprising MTA, HDAC and RBBP
proteins (MHR). We demonstrate that the P1_P2 region of
PWWP2A specifically requires binding to the MTA1 isoform for
recruitment of the entire MHR complex (M1HR). In agreement
with our model of PWWP2A serving as an adapter between H2A.
Z chromatin and histone modifying complexes (such as HDACs),
small interfering RNA (siRNA)-mediated depletion of PWWP2A
results in hyperacetylation of H3K27 and H2A.Z at some
PWWP2A-marked regulatory regions. Overall, our data demon-
strate that PWWP2A recruits the M1HR complex to H2A.Z-
containing chromatin, providing a mechanism by which
PWWP2A cooperates with H2A.Z to regulate chromatin
structure.
Results
PWWP2A’s internal region binds H2A.Z nucleosomes and
DNA. Recently, we showed that the internal region (I) of
PWWP2A, which does not exhibit any sequence homology to
other proteins/protein domains, facilitates binding of PWWP2A
to mononucleosomes in general via its N-terminal part (IN), and
that its C-terminal section (IC) directs specificity for H2A.Z-
containing nucleosomes12. To determine whether IN or IC are
able to directly bind to H2A.Z-containing mononucleosomes or
whether this interaction is indirectly mediated by additional
PWWP2A-associated factors or posttranslational histone mod-
ifications, we carried out in vitro binding assays. We assembled
mononucleosomes with 187-bp DNA (Widom 601-sequence13)
and recombinant histone octamers containing either H2A.Z
or H2A (Supplementary Fig. 1a). The two types of nucleosomes
incorporated distinct fluorescent tags on the DNA, allowing us to
prepare 1:1 mixtures of H2A and H2A.Z nucleosomes and per-
form competitive electrophoretic mobility shift assays (cEMSAs)
using purified recombinant GST-I, GST–IN, or GST-IC proteins
(Fig. 1a and Supplementary Fig. 1b). GST-I bound to both H2A.Z
and H2A nucleosomes, but with a higher preference for H2A.Z
nucleosomes (Fig. 1b). In line with our previous results using cell-
derived mononucleosomes12, IN bound both recombinant H2A
and H2A.Z nucleosomes equally well, while the IC region showed
a clear preference for H2A.Z-containing nucleosomes (Fig. 1b).
Next, we asked whether the nonspecific IN-nucleosome
interaction is mediated either through the histones and/or the
DNA itself. As most proteins recognize the flexible histone tails
rather than the buried histone core regions14, we tested a series of
recombinant nucleosomes containing flexible tail deleted histones
(tail-less, TL) (Supplementary Fig. 1c) in cEMSAs. TL nucleo-
somes did not result in less IN binding, suggesting that the
histone tails themselves are not needed for IN-nucleosome
binding. Interestingly, at the highest protein concentration (80
nM), two shifted bands are present, indicating that each
mononucleosome can presumably be bound by two GST–IN
proteins as two DNA linkers are available. Further, we noticed
that in the presence of linker DNA TL H3 nucleosomes were
bound much better by IN than WT nucleosomes (Fig. 1c). This
observation is in line with published reports showing H3 tail
interacting with linker DNA15,16, thereby possibly preventing
efficient IN recruitment. On the other hand, linker-less TL H4
containing nucleosomes also led to a slight increase in IN binding
(Supplementary Fig. 1d), possibly due to the H4 tail not blocking
the acidic patch of H2A, as published previously17. IN has no
sequence homology with other DNA-binding motifs but is very
conserved between amphibians and mammals (Supplementary
Fig. 1e). To test whether IN could be a possible DNA-binding
domain, we performed EMSAs with free DNA (187 bp) and
observed that IN, but not IC strongly interacts with nucleic acids
(Fig. 1d).
Next, we tested whether DNA binding is the sole mediator
of nucleosome binding and whether IN can recognize
histone-wrapped nucleosomal DNA as well as free DNA.
We performed cEMSAs with recombinant H2A.Z- (Fig. 1e) or
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H2A-nucleosomes (Supplementary Fig. 1f) that either displayed
or lacked linker DNA sequence on either side of the Widom
sequence. In the case of H2A.Z nucleosomes, binding was
observed for all three PWWP2A constructs (I, IN, and IC)
irrespective of the presence of linker DNA; however, both I and
IN constructs showed stronger binding to nucleosomes contain-
ing the linker sequence. In the case of H2A nucleosomes, binding
was much weaker overall but again a preference was observed for
linker-containing nucleosomes. As expected, IC’s nucleosome
binding ability depended almost exclusively on the presence of
H2A.Z and not on the DNA length.
Our data indicate that the IC region of PWWP2A preferably
interacts with H2A.Z-containing nucleosomes, and that the IN
region binds with a preference for free/linker DNA.
PWWP2A’s PWWP domain recognizes H3K36me3. PWWP2A
also contains an evolutionary conserved PWWP domain, which is
characterized by a proline–tryptophan–tryptophan–proline motif
that has been shown to mediate DNA and/or histone H3 lysine 36
trimethylation (H3K36me3) binding in other proteins18,19. We,
therefore, tested whether the PWWP2A PWWP domain is also
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Fig. 1 IC distinguishes between H2A and H2A.Z, whereas IN recognizes nucleosomal linker DNA. a Schematic representation of recombinant
GST–PWWP2A deletions (GST-I, GST–IN, and GST-IC) used in cEMSAs. b Representative cEMSA in which a 1:1 mixture of H2A- and H2A.Z-containing
nucleosomes (each with a distinct fluorescent tag) was incubated with increasing concentrations of GST-tagged I-domain constructs. The top gel shows
detection of the H2A.Z nucleosomes and the bottom gel detection of the H2A nucleosomes. In both cases, the DNA contained a 20-bp linker DNA
(Widom 601-sequence) on each side of the nucleosome (20–Θ–20). GST alone served as negative control. *Free DNA, **nucleosome, ***nucleosome
GST–protein complex. Arrow indicates loss of signal when nucleosome GST–protein complexes are formed. c Left: representative cEMSAs similar to (b)
using recombinant wildtype mononucleosomes (WT, top) or mononucleosomes lacking single histone tails (TL, bottom) containing 20-bp linker DNA (20–
Θ–20). Nucleosomes were incubated with the indicated concentrations of GST–IN and the gel visualized by fluorescence detection of the indicated
nucleosome. Right: quantification of signal intensities of nucleosomes (**) using Image Studio Lite Ver 5.2 (LI-COR). Error bars indicate SEM of three
independent replicates. d Representative EMSA using Cy-5 labeled 187-bp dsDNA and the indicated concentrations of GST–IN and GST-IC. *free DNA,
***DNA–GST–protein complex. Arrow indicates unbound DNA. e Left: representative cEMSAs similar to (b) using recombinant H2A.Z-containing
mononucleosomes without (0–Θ–0, top) and with (20–Θ–20, bottom) linker DNA; these nucleosomes were incubated with the indicated concentrations of
GST-I, GST–IN, and GST-IC. *Free DNA, **nucleosome, ***nucleosome GST–protein complex. Arrow indicates loss of signal when nucleosome GST–protein
complexes are formed. Right: Quantification of signal intensities of nucleosomes (**) using Image Studio Lite Ver 5.2 (LI-COR). Error bars indicate SEM of
three independent replicates
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able to recognize one or even both chromatin features directly.
Previously, we detected low-affinity binding of PWWP2A’s
PWWP domain to free DNA12, but did not investigate whether
this domain is able to recognize histone-bound nucleosomal
DNA as well. cEMSAs with purified recombinant GST–PWWP
(Supplementary Fig. 2a) and recombinant H2A.Z or H2A
nucleosomes with or without linker DNA (Supplementary
Fig. 2b, c) clearly showed the strong dependence of PWWP on
free linker DNA for efficient nucleosome binding (Fig. 2a).
Interestingly, the two observed upshifted bands suggest that two
PWWP domains might bind to one nucleosome simultaneously.
As reported for other PWWP-domain containing proteins
(reviewed in ref. 19), this interaction appears to be only charge
mediated, as the PWWP domain binds equally well to different
types of single and double stranded nucleic acids (Supplementary
Fig. 2d). Comparison of DNA-binding abilities of GST–IN, and
GST–PWWP via EMSA showed that both domains are able to
bind DNA, albeit with different affinities; IN shows a higher
binding affinity than PWWP at 100 and 200 nM, respectively
(Supplementary Fig. 2e).
PWWP domains are characterized by several highly conserved
aromatic cage residues (Supplementary Fig. 2f) that, in other pro-
teins, have been shown to mediate recognition of methylated
histones, most commonly trimethylated H3 lysine 36
(H3K36me3)20. The PWWP2A PWWP domain contains such
amino acids (F666, W669, and W695) that when modeled in
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silico are proposed to form an aromatic cage (Fig. 2b). To
investigate whether PWWP2A can recognize PTMs on histone
tails, we incubated recombinant PWWP2A or its truncations
with micrococcal nuclease (MNase)-digested mononucleosomes
derived from HeLa Kyoto (HK) cells and investigated PTM
enrichment in immunoblots (Fig. 2c). Interestingly, only the
combination of the serine-rich stretch with PWWP domain
(S_PWWP), but not other PWWP2A deletion constructs
efficiently pulled down nucleosomes enriched in H3K36me3
(Fig. 2c). Deletion of the H2A.Z interaction domain IC
(PWWP2A_ ΔIC) led to an increased binding to H3K36me3
from cell-derived mononucleosomes while binding to H2A.Z was
dramatically reduced (Fig. 2d). These data indicate that H2A.Z
binding to the IC region is preferred over H3K36me3 binding to
S_PWWP.
The interaction of S_PWWP with H3K36me3 nucleosomes
depended on a functional aromatic cage, as point mutations of
two of the three aromatic cage residues completely abolished the
interaction with H3K36me3 (Fig. 2e) (without affecting folding,
as determined by nuclear magnetic resonance (NMR) spectro-
metry; Supplementary Fig. 2g). An MS version of the pulldown
assay and subsequent gel-excision of histone bands after IP
(Supplementary Fig. 3a) independently verified the enrichment of
H3K36me3 nucleosomes in pulldowns with S_PWWP (Supple-
mentary Fig. 3b, Supplementary Data 1). In conclusion, the
PWWP2A PWWP domain mediates interactions with chromatin
via nucleic acid binding as well as aromatic cage-dependent
H3K36me3 recognition.
PWWP2A binds H3K36me3 gene bodies and regulatory
regions. Our in vitro data show that PWWP2A strongly interacts
with H2A.Z as well as linker DNA-containing nucleosomes using
its internal domain and is also able to recognize H3K36me3 with
its PWWP domain (Supplementary Fig. 4a). We used our pre-
viously generated GFP–PWWP2A nChIP-seq data12 to ask
whether these in vitro observations are also supported in vivo. We
first searched for gene body regions with high H3K36me3 levels
(ENCODE) by cluster analysis, identifying cluster 2 as prototypic
for H3K36me3-enriched gene body peaks (Fig. 3a). Meta-gene
profile comparison of cluster 2 genes with all other genes verified
the strong enrichment of both PWWP2A and H2A.Z at these
promoters, and also revealed a slight increase in PWWP2A signal
at H3K36me3-positive gene bodies of cluster 2 genes. In contrast,
both H2A.Z isoforms showed a depletion in the gene body
regions (Fig. 3b). Comparison of H3K36me3, GFP–PWWP2A,
and GFP-H2A.Z signals in 3′-gene body ends with the
corresponding non-transcribed downstream regions revealed a
small but significant enrichment of PWWP2A across H3K36me3-
high gene bodies (Fig. 3c and Supplementary Fig. 4b). Recipro-
cally, H2A.Z.1 and H2A.Z.2 were depleted from H3K36me3-
positive gene bodies (Fig. 3c and Supplementary Fig. 4b), showing
that PWWP2A recruitment to those sites is independent of H2A.
Z and likely occurs only in a transient manner.
Recently, we have described PWWP2A as a strong interactor
of H2A.Z, irrespective of whether the latter is located at the TSS
or at other sites in the genome12. To determine whether
PWWP2A is also enriched at other chromatin features/states,
we reanalyzed our recently published nChIP-seq data12. We
compared our data to chromatin states defined by training a
10-state model on ENCODE data for H3K4me3, H3K4me1,
H3K27ac, H3K36me3, and H3K27me3 using ChromHMM21,60.
PWWP2A binding was strongly enriched at active promoters,
which are characterized by high levels of H3K4me3 and H3K27ac
(state 3), as well as active and inactive/poised enhancers,
which are marked by high levels of H3K4me1 and high or low
H3K27ac, respectively (states 4 and 5) (Fig. 4a–c). The
enrichment pattern observed for H2A.Z was very similar to that
of PWWP2A, indicating a common role for both factors at
respective chromatin regions. Intriguingly, H2A.Z and PWWP2A
appear to co-occupy enhancer sites as well (clusters 3 and 4),
suggesting a mechanism by which PWWP2A is recruited to
regulatory regions (Fig. 4c).
Overall, these data show that our in vitro observations
regarding the interactions made by PWWP2A with H2A.Z and
H3K36me3 are recapitulated in vivo and further reveal a
connection of PWWP2A with regulatory regions.
PWWP2A interacts preferentially with an MTA1-specific core
NuRD complex (M1HR). Having determined that PWWP2A
mediates a range of interactions with chromatin via its distinct
domains, we next sought to define the mechanism by which
PWWP2A affects transcriptional regulation12. Because PWWP2A
does not contain any domains with known enzymatic activity, we
speculate that it recruits chromatin modifiers to H2A.Z nucleo-
somes, and possibly to other H3K36me3-enriched sites. We,
therefore, searched for PWWP2A binding partners using the
same assay that we used previously to determine the H2A.Z
interactome12,22. Briefly, chromatin isolated from HK cells stably
expressing GFP or GFP–PWWP2A were digested with MNase to
mononucleosomes (Supplementary Fig. 5a) and immunopreci-
pitated with GFP-TRAP beads. GFP- or GFP–PWWP2A bound
nucleosomal proteins were subjected to on-bead tryptic digestion
Fig. 2 PWWP domain binds nucleic acids and S_PWWP interacts with H3K36me3. a Representative cEMSA using recombinant H2A.Z-containing
mononucleosomes assembled either without (0–Θ–0, top) or with linker DNA (20–Θ–20, bottom) incubated with indicated increasing concentrations of
GST–PWWP. GST alone served as negative control. *Free DNA, **nucleosome, ***nucleosome GST–PWWP complex. Arrow indicates loss of signal when
nucleosome GST–protein complexes are formed. b In silico structure of PWWP domain modeled with the web browser-based tool iTASSER and visualized
with Chimera (1.8.0). β-barrels (β1–β5) are colored in red, α-helixes (α1–α3), and η-helix in blue and the three residues forming the aromatic cage (F666,
W669, and W695) are highlighted in green and depicted in stick mode. NT=N-terminus, CT= C-terminus. c Top left: schematic representation of
recombinant GST–PWWP2A and deletions (GST-P1, GST-I, GST-I_S, GST-I_S_PWWP, GST-S_PWWP, and GST–PWWP) used in cell-derived
mononucleosome-IPs. Top right: Immunoblotting of different histone PTMs upon GST–PWWP2A deletion construct (GST–PWWP2A, GST-P1, GST-I, GST-
I_S, GST-I_S_PWWP, GST-S_PWWP, and GST–PWWP) IPs with HK cell-derived mononucleosomes. Notice enrichment of H3K36me3 in comparison to
other modifications in S_PWWP pulldown. GST alone served as negative control. Bottom: Data quantification was done for three biological replicates for
each PTM (n= 3). Data shown are means and error bars depict SEM. d Left: immunoblotting of H3K36me3 and H2A.Z upon GST–PWWP2A, GST-
PWWP2A_ΔIC and GST-S_PWWP IPs with HK cell-derived mononucleosomes. Right: Data quantification of H3K36me3 enrichment (middle) and H2A.Z
binding (right) was done for three biological replicates (n= 3). Data shown are means and error bars depict SEM. e Left: immunoblotting of H3K36me3
upon GST-S_PWWP aromatic cage point mutants (GST-S_PWWP_F666A, GST-S_PWWP_W669A, GST-S_PWWP_W695A) IPs with HK cell-derived
mononucleosomes. Notice reduction of H3K36me3 in GST-S_PWWP_W669A and GST-S_PWWP_W695A pulldowns. Right: Data quantification was
done for three biological replicates (n= 3). Data shown are means and error bars depict SEM
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and then quantitated by label-free MS/MS. Identification of H2A.
Z as one of many PWWP2A targets provided confidence in
the approach (Fig. 5a and Supplementary Fig. 5b). We detected
several proteins and subunits of protein complexes previously
identified to also interact with H2A.Z (e.g., BAHD1, BRWD3,
HMG20A, PHF14, PHF20L1, RAI1, and ZNF512B) and some
that appear to be PWWP2A-specific (e.g., ATRX, DAXX, MDC1,
and PWWP2B). Interestingly, among the proteins that were
previously shown to precipitate with H2A.Z, strongest binding
and collective clustering in volcano plot (Fig. 5a) was observed for
MTA1, HDAC2, RBBP4, and RBBP7, which are core components
of the nucleosome remodeling and deacetylase (NuRD) complex
that is involved in gene regulation23, and implicated in cancer and
various other diseases6. PWWP2A binding to HDAC1/2 has been
previously reported24, further corroborating our data. Usually,
NuRD also contains MBD2/3, GATAD2A/B and the ATP-
dependent remodeling enzymes CHD3/4/56. Surprisingly, none
of these subunits were isolated in our PWWP2A (Fig. 5a, b, and
Supplementary Fig. 5b) or H2A.Z pulldowns12, suggesting that
the MTA, HDAC and RBBP subunits constitute an independently
stable subcomplex that we named MHR after its constituents. A
corresponding PMR complex has been identified in Drosophila25,
which contains the three homologous proteins (p55, MTA-like,
and Rpd3). First, we wondered whether PWWP2A is able
to equally interact with all MTA isoforms, which differ mainly
in their C-terminal regions (Fig. 5c). We performed tagged MTA
isoform-specific IPs followed by immunoblotting for PWWP2A
and, as positive control, MBD3. We found that PWWP2A
showed strongly enriched binding to MTA1 over MTA2 or
MTA3 (Fig. 5c). Similarly, in a reciprocal experiment, only MTA1
but not MBD3 was able to efficiently pulldown PWWP2A
(Supplementary Fig. 5c), confirming MTA1–PWWP2A
association without MBD3 presence. To determine which subunit
(s) of the MHR complex is responsible for mediating the inter-
action with PWWP2A, a FLAG-PWWP2A IP was performed
with cell lysates from HEK293 cells coexpressing FLAG-
PWWP2A, HDAC1 (untagged), HA-RBBP4 and either HA-
MTA1 or HA-MTA2 (Fig. 5d). Remarkably, only in the presence
of MTA1, but not MTA2, PWWP2A pulled down all components
of the MHR complex, suggesting that MTA1 is the direct binding
partner of PWWP2A and mediates the recruitment of HDAC
and RBBP proteins to form an MTA1-specific M1HR module.
We hypothesize that PWWP2A might compete with the
MBD–GATA–CHD (MGC) subunits for binding to the M1HR
module, explaining why MBD, GATA and CHD proteins are not
enriched in PWWP2A purifications.
We next assessed which region(s) of PWWP2A is responsible
for mediating the MTA1–PWWP2A interaction. We incubated
recombinant GST-tagged PWWP2A deletions with lysate from
HEK293 cells expressing full-length MTA1-HA. The strongest
interaction was observed with a fragment containing the P1, P2,
and I regions of PWWP2A, and a weaker interaction was
observed with the P1 domain alone (Fig. 5e). The importance of
the P1_P2_I region for M1HR recruitment was also confirmed for
endogenous MTA1 and HDAC2 when using recombinant
GST–PWWP2A deletions incubated with HK cell-derived
mononucleosomes (Supplementary Fig. 5d). As neither the I or
P1 domain alone nor the P2_I region were able to bind MTA1, we
speculate that the P2 domain contributes the most to the
interaction with MTA1, most likely with some contribution from
the P1 domain.
In summary, we have identified a specific and direct interaction
of PWWP2A with a core M1HR complex that is mediated via the
P1_P2 region in PWWP2A.
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Fig. 3 PWWP2A associates weakly with H3K36me3-enriched, H2A.Z-depleted gene body regions. a ChIP-seq density heatmap of H3K36me3 (ENCODE)
clustering analysis of meta-gene binding profiles encompassing gene bodies and 6 kb upstream and downstream regions of transcriptional start sites (TSS)
and transcriptional end sites (TES). Color intensity represents normalized and scaled tag counts. Cluster 2, which represents H3K36me3-enriched genes,
was used for further analysis. b Meta-gene profile correlations of ChIP-seq data for H3K36me3, two GFP–PWWP2A replicates (rep), GFP-H2A.Z.1, and
GFP-H2A.Z.2 mean coverage signals of cluster 2 genes (red line) and all genes (black dotted line) encompassing gene bodies and 6 kb upstream and
downstream regions of TSS and TES. Regions highlighted in light blue (gene body) and light green (downstream region) were further analyzed in (c).
GFP–PWWP2A and GFP-H2A.Z nChIP-seq data are from12. (c) Boxplots of H3K36me3, two independent GFP–PWWP2A, GFP-H2A.Z.1, and GFP-H2A.
Z.2 signal intensities comparing gene body with non-coding regions of same size within cluster 2
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PWWP2A loss affects histone acetylation at regulatory sites.
PWWP2A not only co-localizes with H2A.Z at the TSS and to a
lesser extent with H3K36me3-enriched gene bodies, but also co-
occupies regulatory regions marked by high H3K27ac levels
(Fig. 4c). Previously, it was shown that H3K27ac levels correlate
with activity of the NuRD complex26. The PWWP2A-associated
M1HR complex that we identified contains the enzymatically
active histone deacetylase HDAC2 that was also found to bind to
H2A.Z-containing nucleosomes12, as well as HDAC1. HDACs
are generally believed to act as transcriptional corepressors by
removing transcription-promoting histone acetylation marks27,28.
However, recent experiments showed a strong association of all
HDAC classes with active genes, in particular at gene promoters
and enhancers29,30. These data sets nicely correlate with our
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observation that HDAC2 and HDAC1 are bound to H2A.Z and
PWWP2A, which both localize to the well-positioned −1 and +1
nucleosomes at the TSS of actively transcribed genes12 and reg-
ulatory regions (Fig. 4c). Hence, we next wondered whether the
H2A.Z–PWWP2A–M1HR connection is able to affect histone
acetylation levels. As H3K27ac shares a substantial number of
binding sites across the genome with acetylated H2A.Z (H2A.Zac,
which can be acetylated at lysines 4, 7, and 11) at active TSS and
enhancers (Supplementary Fig. 6), we analyzed H3K27ac as well
as H2A.Zac levels after PWWP2A knockdown via nChIP-seq.
Focusing on genome-wide distribution patterns of our H3K27ac
or H2A.Zac nChIP-seq data indicated that the vast majority of
sites were co-occupied by PWWP2A (Fig. 4c, Fig. 6a, Supple-
mentary Fig. 6a, b). Strikingly, loss of PWWP2A led to a strong
increase of H3K27ac and H2A.Zac levels at a relatively small, but
reproducibly detectable fraction of 566 sites typically bound by
PWWP2A and H2A.Z (Fig. 6a, b, Supplementary Fig. 7). Strin-
gent data analysis revealed that this differential increase of H3K27
acetylation levels after PWWP2A depletion at these sites was
likewise apparent at the majority of H2A.Zac sites and vice versa
(Fig. 6b). The increase in acetylation predominantly occurred at
distal intergenic regions (Supplementary Fig. 6c). To test whether
the increase in acetylation on H3K27ac and H2A.Zac affects the
expression of nearby genes, we analyzed expression levels via real-
time quantitative polymerase chain reaction (RT-qPCR) and
performed nChIP-qPCR to validate nChIP-seq results from
corresponding regulatory regions (Fig. 7c). We found that the
highly reproducible differential acetylation on H3K27ac as well
as H2A.Zac led to the upregulation of expression of some genes
(e.g., CCL5 and FST), while the expression levels of other genes
remained unchanged (e.g., ZNF19 and B3GALNT2) (Fig. 6c,
Supplementary Fig. 7).
Our data suggest that PWWP2A serves as an adapter between
H2A.Z chromatin and the HDAC-containing M1HR complex,
promoting in some cases changes in histone acetylation levels.
Discussion
We have identified PWWP2A as a multivalent, high-affinity
chromatin binder that directly interacts with at least five different
chromatin moieties (free DNA, histones, H2A.Z, H3K36me3,
and nucleic acids) by utilizing at least four different domains
(IN, IC, S_PWWP, and PWWP) (Supplementary Fig. 4a and
Fig. 7). The functional consequences of PWWP2A’s capability to
selectively and/or synchronously bind distinct genomic sites and
to recruit several chromatin-modifying proteins, such as the
M1HR complex, are potentially complex. While direct H2A.Z
nucleosome binding via the internal region appears to be
responsible for PWWP2A’s recruitment to enhancers and pro-
moters of highly active genes, interaction of the S_PWWP
domain with H3K36me3 is functionally more enigmatic. It has
been noted for several other proteins, including ZMNYD11 that
the PWWP domain alone is not sufficient for chromatin
recruitment and a combination of the PWWP domain with an
adjacent domain is needed for proper binding of H3K36me331.
Although the recognition of this PTM, which is found at gene
bodies of transcribed genes and is involved in suppressing cryptic
transcript initiation32,33, is observed for recombinant S_PWWP,
constructs that include the H2A.Z-specific internal region—
including full-length PWWP2A—are unable to bind H3K36me3
efficiently. We speculate that H2A.Z binding to the internal
region of full-length PWWP2A is preferred over a
PWWP2A–H3K36me3 association. This hypothesis is supported
by our findings that PWWP2A lacking the H2A.Z-specificity
module IC loses H2A.Z–nucleosome interaction, while at the
same time it shows enhanced binding to H3K36me3-containing
nucleosomes. How differential chromatin-state recognition by
PWWP2A is regulated and possibly ‘switchable’ is not clear. We
postulate that either IC binding to H2A.Z–nucleosomes dom-
inates over S_PWWP–H3K36me3 interaction or that an element
in the I domain might auto-inhibit the S_PWWP domain. The
latter mechanism could be regulated by dynamic covalent mod-
ifications of PWWP2A that modulate its ability to bind these two
mutually exclusive chromatin moieties. Intriguingly, the I domain
harbors a number of sites that are potentially subject to lysine
acetylation and also several potential phosphorylation sites. Fur-
ther work will be required to test the hypothesis that modifica-
tions of PWWP2A in response to external signals might regulate
its binding activity. Nevertheless, our finding that PWWP2A is
able to bind distinct chromatin moieties is in line with the
observation that full-length PWWP2A protein is mainly found at
H2A.Z-containing promoter nucleosomes in nChIP-seq and that
only a minor fraction is found at H3K36me3-positive gene
bodies.
In line with its putative role as a transcriptional coregulator, we
predicted that PWWP2A would bind to a range of chromatin-
modifying proteins and complexes. Affinity purification of tagged
PWWP2A from HK cells revealed a number of significantly
enriched proteins, most of which were identified previously in an
H2A.Z pulldown12, several others appeared to be PWWP2A-
specific, such as PWWP2B, MDC1, DAXX and ATRX. Three of
the six core components of the NuRD complex—the MTA,
HDAC, and RBBP subunits—were among the most enriched
binding partners for PWWP2A in our affinity purification. Sur-
prisingly, the MBD, GATAD2, and CHD subunits, which account
for the chromatin remodeling and methyl-DNA binding func-
tions of the NuRD complex, were not observed at significant
levels.
Although several forms of the NuRD complex have been
observed previously, these variants have largely been confined to
paralogue switching—MBD2 versus MBD3, for example, or the
inclusion of additional subunits such as CDKAP18,9,34. Zhang
et al.25 reported that they were able to isolate a stable and cata-
lytically active complex from Drosophila cells that is the
equivalent of our M1HR complex, although they did not
demonstrate that this complex had a function in vivo. We
recently showed that CHD4 is a peripheral component of the
NuRD complex and our data, together with the findings of Zhang
Fig. 4 PWWP2A associates with regulatory regions genome-wide. a ChromHMM21,60-based characterization of chromatin states of PWWP2A-containing
genomic regions. The heatmap depicts the emission parameters of the HMM and describes the combinatorial occurrence of the individual histone
modifications in different chromatin states. b Chromatin-state enrichment of PWWP2A- or H2A.Z.1-enriched sites compared to complete human genome
(left) and log2-fold enrichment or depletion of PWWP2A sites in specific states calculated to frequency in complete genome (right). Notice enrichment of
PWWP2A in states 1–5 that resemble promoter and enhancer regions. c nChIP-seq density heatmap of PWWP2A enriched sites (two replicates, green)
and visualization of the intensities of H3K4me3 (dark blue, ENCODE), H3K4me1 (light blue, ENCODE), H3K27ac (yellow, ENCODE), and H2A.Z1 and H2A.
Z.2 variants (red) at these regions. Color intensity represents normalized and globally scaled tag counts. Notice PWWP2A is found at active promoter
regions (H3K4me3+, H3K4me1−, H3K27ac+) encompassing clusters 1 and 2, as well as active (cluster 3: H3K4me3+, H3Kme1+, H3K27ac+) and
inactive (cluster 4: H3K4me3−, H3K4me1+. H3K27ac−) enhancers, all containing H2A.Z variants
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06665-5
8 NATURE COMMUNICATIONS |  (2018) 9:4300 | DOI: 10.1038/s41467-018-06665-5 | www.nature.com/naturecommunications
12
3
4
5
6
7
–
Lo
g1
0 
p-
va
lu
e
PHF20L1
MTA1(H0Y4T7)
MTA2
PHF14
H2AZ
ATRX
RBBP4
RBBP4(Q09028-2)
MTA1
MTA1(Q13330-3)
HDAC1
MDC1
RBBP7
PWWP2B
BRWD3
RAI1
BAHD1
HDAC2
ZNF512B
PWWP2A
MTA3
HMG20A
DAXX
TCF20
–12 –10 –8 –6 –4 –2 0 2 4 6 8 10 12
T-test difference
GFP GFP-PWWP2A
MTA1
HDAC2
RBBP7
RBBP4
CHD4
H3
kDa
55
70
40
40
250
15
PWWP2A
kDa
50
35 MBD3
70
IP IP IP
SANTELM2BAH
SH3-binding SIM
MTA1
SANTELM2BAHMTA2
SANTELM2BAHMTA3
Zinc finger GATA-type
668
594
HA-MTA1
HA-MTA2
Tagless-HDAC1
HA-RBBP7
FLAG-PWWP2A +
+
–
+
+
+
–
+
+
+
kDa
66
97
116
55HDACs
RBBPs
FLAG-IP
+
+
–
+
+
+
–
+
+
+
Input
PWWP2A
MTA1
MTA2
1
1
575
575291
575 755
146
21
31
36
66
97 MTA1-HA
632 655146 715291 755575
P1 P2 IN IC S PWWP
IPWWP2A 
0
Inp
ut 
(0.8
 %)
GS
T
GS
T-P
WW
P2
A
Inp
ut
IgG MT
A1
-FL
AG
Inp
ut
IgG MT
A2
-G
FP
Inp
ut
IgG MT
A3
-FL
AG
P1 P1
_P
2_
I
I S_
PW
WP
P1 P1
_P
2_
I
I S_
PW
WP
a b
c
d e
Fig. 5 PWWP2A interacts with members of a core NuRD complex via MTA1. a Volcano plot of label-free interaction of GFP–PWWP2A-associated
mononucleosomes. Significantly enriched proteins over GFP-associated mononucleosomes are shown in the upper right part. t test differences were
obtained by two-sample t test. PWWP2A is highlighted in green, members of the core NuRD (M1HR) complex in red, previously identified H2A.Z-
mononucleosome binders12 in blue, PWWP2A-specific interactors not found in H2A.Z pulldowns12 in black and background binding proteins in gray.
b Immunoblots of several NuRD members (MTA1, HDAC2, RBBP7, RBBP4, and CHD4) and H3 upon GST and GST–PWWP2A IP with HK cell-derived
mononucleosomes. c Upper part: schematic depiction of mammalian MTA1-3 paralogues. Lower part: immunoblots of PWWP2A or MBD3 after IP of
endogenously tagged MTA1–FLAG, MTA2–GFP, or MTA3–FLAG from mouse embryonic stem cell (mESC) nuclear extracts. Input lanes represent 10%
of the lysate used for the IP. d FLAG-PWWP2A IPs with cell lysates from HEK293 cells co-transfected with combinations of plasmids encoding
FLAG-PWWP2A, HDAC1 (tagless), HA-RBBP4, and either HA-MTA1 or HA-MTA2. Left panel: western blot of inputs. Right panel: SYPRO Ruby-stained
SDS-PAGE of the precipitated proteins. e Top: schematic depiction of domain structure of PWWP2A and deletion constructs. Bottom: coomassie-stained
SDS–PAGE gel with indicated recombinant PWWP2A deletion constructs on beads (left) and immunoblots of IPs from lysates from HEK293 cells
expressing HA-MTA1 (right)
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et al., suggest that NuRD might be assembled from two modules:
one comprising HDAC, MTA and RBBP subunits in a 2:2:4 ratio
and the other comprising a GATAD2, MBD, and CHD sub-
unit25,35. The data presented here demonstrate a function for one
of these modules in isolation.
We have previously shown that MBD3 can interact directly
with an MTA subunit36, indicating that MBD3 constitutes a
bridge between the MHR complex and the CHD remodeling
subunit. The data we present here suggest that PWWP2A directly
competes with MBD3 for binding to MTA1, providing a
mechanistic explanation for the lack of enrichment of MBD,
GATAD2, and CHD proteins in the PWWP2A pulldowns. The
findings also raise the likely possibility that other proteins can act
to decouple the MHR complex from the remainder of NuRD.
The preference of PWWP2A for binding M1HR over M2HR,
which we could recently also confirm in another independent
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study using MTA isoform-specific pulldowns and MS identifi-
cation37, was also unexpected and points to another mechanism
by which paralogue choice in NuRD has functional consequences.
We also note that despite the clear preference for MTA1 in our
direct interaction experiments, MTA2 and MTA3 were identified
in our purification of cellular PWWP2A. Because the MHR
complex contains two copies of an MTA subunit, it is quite
possible that either MTA2 or MTA3 can be “brought along for
the ride” in an MHR complex containing one copy of MTA1 and
one copy of a different MTA—and that PWWP2A interacts only
with the MTA1 subunit. This hypothesis remains to be tested.
We hypothesize that depletion of PWWP2A leads to reduced
recruitment of M1HR, and that the resulting loss of HDAC
activity is what leads to the observed increase in H3K27 acet-
ylation. Regulation of acetylation levels by HATs and HDACs
is important to balance transcriptional output29. Because
PWWP2A is a strong binder of H2A.Z, we additionally investi-
gated acetylation levels of H2A.Z, which mainly localize at
enhancers and promoters of actively transcribed genes38,39. Both
PTMs, as well as NuRD, are found at active promoters and might
play important roles in transcriptional regulation, especially
during development11,40. Previously, we found ~600 genes to be
deregulated upon PWWP2A knockdown12. Indeed, we found
that a fraction of nearby acetylation sites of upregulated genes
shows an increase in acetylation levels. Since it is largely unknown
which genes are influenced by which distant regulatory regions it
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Fig. 7Model of PWWP2A recruitment to chromatin and binding to M1HR complex. PWWP2A is able to interact with different chromatin states via distinct
domains. It binds weakly to H3K36me3-enriched gene body regions using aromatic cage residues in its S_PWWP domain and recognizes free nucleic acid
strands with the PWWP domain. Additionally, PWWP2A binds strongly to H2A.Z-containing promoter and regulatory sites with the IN domain interacting
with linker DNA and the IC region mediating H2A.Z–nucleosome specificity. On chromatin, PWWP2A serves as adapter between distinct nucleosome
components (H3K36me3 or H2A.Z) and chromatin-modifying complexes. Notably, H2A.Z-bound PWWP2A interacts with a MTA1-specific core NuRD
complex (M1HR), preventing formation of full NuRD (+CHD/MBD/GATA subunits) by competing with the MTA-MBD interaction. PWWP2A thereby
leads to the recruitment of HDAC1/2 to promoter and regulatory regions, resulting in turn in the deacetylation of nearby H3K27 and H2A.Z. This activity
could dampen transcriptional output by reducing acetylation of regulatory regions to prevent hyperacetylation at active genomic sites
Fig. 6 Depletion of PWWP2A mediates increase of H3K27 and H2A.Z acetylation. a nChIP-seq density heatmap of 566 induced H3K27ac sites upon
PWWP2A-depeletion. H3K27ac (yellow) and H2A.Zac (red) mark intensities at these regions upon control (wt, Luci) or PWWP2A (PW#1, PW#2) siRNA-
mediated knockdown. Color intensity represents normalized and globally scaled tag counts. Notice strong signal intensity increase of H3K27ac and H2A.
Zac upon PWWP2A depletion at PWWP2A-bound regions (green, two replicates are shown). b Boxplots showing quantification of binding events at
566 sites differentially acetylated at H3K27 (p < 0.001) after siRNA-mediated knockdown of PWWP2A (top). Plots indicate that the majority of the
observed acetylation changes were characterized by induction of acetylation (p value: sig. H3K27ac versus all: p < 2.2e−16). These sites show
simultaneous induction of H2A.Zac, although not as strongly pronounced as for H3K27ac (p value < 2.2e−16) (top). Analysis of differentially regulated
H2A.Zac (423 sites, bottom) indicates prevalent induction of acetylation (p value < 2.2e−16). These sites show simultaneous induction of H3K27ac,
although not as strongly pronounced as for H2A.Zac (p value < 2.2e−16). Boxplots represent the median and first and third quartiles with whiskers
indicating the most extreme data point that is no more than 1.5 times the length of the box away from the box. c Top: validation of nChIP-seq by nChIP-
qPCR at selected loci. Shown is percent input of two replicates of H3K27ac or H2A.Zac nChIPs upon control (wt, Luci) or PWWP2A (PW: PW#1, PW#2)
siRNA-mediated knockdown. Error bars depict SEM (n= 4). Notice two different classes of genes/loci: Increase of acetylation levels on H3K27ac and H2A.
Zac can result in (i) upregulation of expression of a nearby gene (CCL5, FST) or (ii) no change in expression of a nearby gene (ZNF19 and B3GALTN2);
CCDC71 represents a locus where acetylation level and gene expression remain unchanged. TSS: transcriptional start site, remote: regulatory region close
to a gene. Bottom: Relative expression of selected genes corresponding to differentially acetylated sites (upper panel) after control (wt, Luci) or PWWP2A
(PW: PW#1, PW#2) siRNA-mediated knockdown. Shown is the fold change of three replicates normalized to HPRT expression. Error bars depict SEM (n=
6). Notice upregulation of gene expression of only CCL5 and FST
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is difficult to faithfully determine corresponding genes. As
changes in chromatin environment go hand-in-hand with
transcriptional regulation, the increase in acetylation levels on
H3K27 and H2A.Z provides a mechanistic explanation for the
observed transcriptional deregulation. It has been suggested that,
in mESCs, NuRD acts as a transcriptional modulator that is
involved in maintaining bivalency presumably by removing the
active H3K27ac mark and consequently promoting H3K27 tri-
methylation11,26,41. We propose that PWWP2A recruits HDACs
in the context of M1HR complex, to transcriptionally active or
bivalent H2A.Z-containing regions in order to balance tran-
scriptional output at these sites. Both HDAC 1 and 2 are found at
promoters of active genes29, which fits well with our hypothesis
that a core NuRD complex is recruited to H2A.Z-containing
promoters of highly transcribed genes via interaction with
PWWP2A. Alternatively, PWWP2A–M1HR’s primary targets
may not be histones but other proteins, such as chromatin
modulators and transcription factors (TFs). It is known that the
acetylation status of TFs influence their gene regulatory activ-
ities42,43, therefore, loss of PWWP2A and consequent delocali-
zation of a fraction of HDAC1/2 might lead to changes in TF
acetylation and explain the observed upregulation as well as
downregulation of genes12.
Studies in differentiation systems, where dynamic chromatin is
even more relevant, and development of inducible PWWP2A
knockouts and rescue experiments, will help to shed light on the
functional connection between PWWP2A and M1HR. Such
studies might reveal how the PWWP2A–M1HR complex, and/or
the binding of PWWP2A to other complexes regulates mitotic
progression and cranial–facial development.
In summary, we show that PWW2A uses at least four different
domains to bind different chromatin moieties. We propose that
PWWP2A acts to recruit M1HR to H2A.Z-containing chromatin
that aids in balancing acetylation states.
Methods
Cell culture. HK cells12, kind gift from Heinrich Leonhardt (LMU Munich), were
grown in Dulbecco’s modified Eagle’s medium (DMEM, Sigma) supplemented
with 10% fetal calf serum (FCS; Sigma) and 1% penicillin/streptomycin (37 °C, 5%
CO2). HK cells stably expressing eGFP or eGFP-tagged PWWP2A were previously
described12, and are routinely tested for mycoplasma contamination.
The EXPI293F™ cells are originally from Life Technologies (now ThermoFisher
Scientific, Cat no. #A14527). This cell line is derived from the HEK293-F cell line,
which was derived from the HEK293 cell line. As for accession numbers, the
HEK293-F and HEK293 cell lines have ExPASy accession numbers CVCL_6642
and CVCL_0045, respectively.
Mouse ESCs (mESCs) are derivatives from the E13tg2a parent line and were
grown on 0.1% gelatin in 2i/LIF conditions as previously described44. Mbd3 floxed
cells in which tagged MTA cell lines were made are described in ref. 45. The
epitope tagged mESC lines (Mbd3-Avi-3 × FLAG, Mta1-Avi-3 × FLAG,
Mta2–GFP, and Mta3-Avi-3 × FLAG) were made by standard gene targeting
methods37.
siRNA transfections. siRNAs were designed using siDESIGN Center (http://
dharmacon.gelifesciences.com/design-center/?redirect=true) and synthesized
(MWG-Biotech AG). siRNAs were prevalidated by BLAST searches (NCBI) to
confirm their targeting specificity to PWWP2A and to reduce the chance of off-
target effects. PWWP2A-specific siRNAs were described before12. The following
double stranded siRNAs were used: Luciferase, 5′-CUUACGCUGAGUACUUC
GA-3′; PWWP2A#1, 5′-GGACAGAAGUCAAGUGUGAUUTT-3′; PWWP2A#2,
5′-GCUAUUAAACUACGACCCAUUTT-3′. Cells were transfected with siRNA
using oligofectamine (Invitrogen) according to the manufacturer’s instructions.
Two days after transfection, cells were harvested for RNA extraction and nChIP
experiments.
Plasmids. For expression in bacteria, PWWP2A cDNA was cloned into a pGEX-
6P1 (Amersham) plasmid and PWWP2A deletions were cloned as previously
described12. GST-PWWP2A_ΔIC was generated via Gibson Assembly (New
England Biolabs) using the following oligos:
F: 5′-CCAGAGTAAGAACTCTGACTCTTCCAGTGC TTC-3′ and
R: 5′-TGGAAGAGTCAGAGTTCTTACTCTGGAGAACTTTTTTAGTAC
TTAACTG-3′ single point mutations in pGEX-6P1-S_PWWP were introduced
using site-directed mutagenesis with the following primers:
S_PWWP_F666A: 5′-CAAGATATATGGCGCCCCTTGGTGGCCAG-3′
S_PWWP_W669A: 5′-GGCTTCCCTTGGGCGCCAGCCCGTATTC-3′
S_PWWP_W695A: 5′-GAGGCCCGTATTTCAGCGTTTGGGTCTCC-3′
PCR was performed under standard conditions with 20 cycles and the template
plasmid DPNI digested. The newly amplified plasmid, containing the desired
mutations, was transformed into DH5α (Genentech). Correct sequences of all DNA
products established by PCR-induced mutagenesis or cloning were verified by
sequencing (MWG).
For expression in human cells, PWWP2A cDNA was cloned into a pIRESneo-
EGFP plasmid12, generated from pIRESneo (EcoRV and BamHI digest) with an
EGFP insert from pEGFP-C1 (NheI digest followed by Klenow reaction and
BamHI digest).
The pcDNA3.1 expression vector was used for transfection of suspension-
adapted HEK Expi293FTM cells. Full-length genes for human PWWP2A (UniProt
ID: Q96N64), RBBP7 (UniProt ID: Q16576), mouse MTA2 (UniProt ID: Q9R190),
human MTA1 (UniProt ID: Q13330), and human HDAC1 (UniProt ID: Q13547)
were cloned with or without N-terminal FLAG- and HA-tags.
Antibodies. The following commercially available antibodies were used:
Anti-H3 (1:5.000, #61475), anti-H3K36me3 (1:4.000, #61102), anti-H3K36me2
(1:1.000, #39255), anti-H3K36me1 (1:1.000, #61351), anti-H3K4me3 (1:500,
#61379) and anti-H2A (1:1.000, #39209) were from Active Motif. Anti-H3K27me3
(1:1.000, C15410069), anti-H3K79me3 (1:1.000, C15310068), anti-H2A.Zac
(2 µg/IP, C15410202-050) and anti-H3K9me3 (1:1.000, C15410056) were from
Diagenode. Anti-H4K20me3 (1:1.000, ab9053), anti-H3 (1:30.000, ab1791), anti-
MTA1 (1:1.000, ab71153 or 3 µg/IP, ab50209), anti-CHD4 (1:1.000 or 2 µg/IP,
ab70469), anti-HDAC2 (1:5.000, ab124974) anti-RBBP4 (1:1.000, ab488), anti-
RBBP7 (1:1.000, ab3535), anti-H3K27ac (2 µg/IP, ab4729), anti-H2A.Z (1:3.000,
ab4174), and anti-MBD3 (1:5.000, ab157464) were from Abcam. Anti-PWWP2A
(1:1.000, NBP2-13833) from Novus (Acris). Anti-HA-HRP (1:40.000, 2999S) and
anti-HDAC1 (1:20.000, 5356S) from Cell Signaling Technology. Anti-FLAG M2
(1:80.000 or 3 µg/IP, F1804) and anti-mouse IgG (3 µg/IP, I8765) from Sigma-
Aldrich.
The following secondary antibodies were used:
Anti-rabbit IRDye 800CW (1:10.000, 926-32211) and anti-mouse IRDye 680RD
(1:10.000 926‐68070) from LI-COR Biosciences. Anti-mouse-HRP (1:10.000,
M114) from Leinco Technologies. Anti-mouse and anti-rabbit HRP-linked
antibodies (1:10.000, NA931 and NA934) from VWR.
MS identification of histone modifications. Sample preparation: immunopreci-
pitated protein-fractions, separated by a 4–20% gradient sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS–PAGE) (SERVA), were stained with
Coomassie (Brilliant blue G-250) and protein bands in the molecular weight range
of histones (15–23 kDa) were excised as single band/fraction. Gel pieces were
destained in 50 % acetonitrile/ 50 mM ammonium bicarbonate. Lysine residues
were chemically modified by propionylation (30 min, RT) with 2.5 % propionic
anhydride (Sigma) in ammonium bicarbonate (pH 7.5) to prevent tryptic cleavage.
This step only added a propionyl group to unmodified and monomethylated
lysines, whereas lysines with other side chain modification will not obtain an
additional propionyl group. Subsequently, protein digestion (200 ng of trypsin
(Promega)) in 50 mM ammonium bicarbonate was performed (overnight (ON))
and the supernatant was desalted by C18-Stagetips (reversed-phase resin) and
carbon Top-Tips (Glygen) according to the manufacturer’s instructions. Following
carbon stage tip, the dried peptides were resuspended in 17 μl of 0.1 % TFA.
LC-MS analysis of histone modifications: 5 µl of each sample were separated on a
C18 home-made column (C18RP Reposil-Pur AQ, 120 × 0.075mm× 2.4 μm, 100 Å,
Dr. Maisch, Germany) with a gradient from 5 % B to 30 % B (solvent A 0.1 % FA in
water, solvent B 80 % ACN, 0.1 % FA in water) over 32min at a flow rate of 300 nl/
min (Ultimate 3000 RSLC Thermo-Fisher, San Jose, CA) and directly sprayed into a
Q-Exactive HF mass spectrometer (Thermo-Fisher Scientific). The mass spectrometer
was operated in the PRM mode to identify and quantify specific fragment ions of N-
terminal peptides of human histone H3.1 and histone H4 proteins. In this mode, the
mass spectrometer automatically switched between one survey scan and 9 MS/MS
acquisitions of the m/z values described in the inclusion list containing the precursor
ions, modifications and fragmentation conditions (Supplementary Data 1).
Survey full scan MS spectra (from m/z 250–800) were acquired with resolution
30,000 at m/z 400 (AGC target of 3 × 106). PRM spectra were acquired with
resolution 15,000 to a target value of 2 × 105, maximum IT 60ms, isolation window
0.7 m/z and fragmented at 27% normalized collision energy. Typical mass
spectrometric conditions were: spray voltage, 1.5 kV; no sheath and auxiliary gas
flow; heated capillary temperature, 250 °C.
Quantification of histone modifications: Data analysis was performed with
Skyline (version 3.6)46 by using doubly and triply charged peptide masses for
extracted ion chromatograms (XICs). Peaks were selected manually and the
integrated peak values (Total Area MS1) were exported as.csv-file for further
calculations. The percentage of each modification within a given peptide is derived
from the ratio of this structural modified peptide to the sum of all isoforms of the
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corresponding peptides. Therefore, the Total Area MS1 value was used to calculate
the relative abundance of an observed modified peptide as percentage of the overall
peptide. Coeluting isobaric modifications were quantified using three unique MS2
fragment ions. Averaged integrals of these ions were used to calculate their
respective contribution to the isobaric MS1 peak (e.g.,: H3K36me3 and
H3K27me2K36me1).
Percentage values of each modification were normalized to percentage values of
Input samples and plotted with Perseus software version 1.5.1.6 with euclidean
clustering and subsequent visualization in heatmaps47. Default settings were used
for analysis in Perseus.
Label-free quantitative MS. The sample preparation of HK cell-derived
mononucleosomes and following label-free quantitative MS were carried out as
previously described12 with the following differences:
LC-MS/MS analysis: Peptides were analyzed by reversed-phase liquid
chromatography on an EASY-nLC 1000 or 1200 system (Thermo Fisher Scientific,
Odense, Denmark) coupled to a Q Exactive plus or HF mass spectrometer (Thermo
Fisher Scientific). HPLC columns of 50 cm length and an inner diameter of 75 µm
were in-house packed with ReproSil-Pur 120 C18-AQ 1.9 µm particles (Dr. Maisch
GmbH, Germany). Peptide mixtures were separated using linear gradients of 120
or 140 minutes (total run time+washout) and a two buffer system: buffer A++
(0.1% formic acid) and buffer B++ (0.1% formic acid in 80% acetonitrile). The
mass spectrometer was operated in a data-dependent top 10 or top 15 mode.
Peptides were fragmented by higher energy collisional dissociation (HCD) with a
normalized collision energy of 27.
MS Data analysis: MS raw data were processed using the MaxQuant software
version 1.4.3.1348. Fragmentation spectra were searched against a human sequence
database obtained from Uniprot in May 2013 and a file containing frequently
observed contaminants such as human keratins. Cysteine carbamidomethylation
was set as a fixed modification; N-terminal acetylation and methionine oxidation
were set as variable modifications. Trypsin was chosen as specific enzyme, with 2
maximum missed cleavages allowed. Peptide and protein identifications were
filtered at a 1% FDR. Label-free quantification was performed using the MaxLFQ
algorithm49 integrated into MaxQuant. The match between runs option was
enabled with a matching time window of 0.5 min and an alignment time window of
20 min. All other parameters were left at standard settings. MaxQuant output tables
were analyzed in Perseus47 version 1.5.8.6 as follows: After deleting proteins only
identified with modified peptides, hits to the reverse database, contaminants and
proteins with one or less razor and unique peptides, label-free intensities were log2
transformed. Next, proteins were required to have 3 valid values in at least one
triplicate, then remaining missing values in the data matrix were imputed with
values representing a normal distribution around the detection limit of the mass
spectrometer. Now a two-sample t test was performed to identify proteins enriched
in the PWWP2A pulldowns compared input control. Only those proteins were
kept for further analysis. Significant outliers were determined using a permutation-
based FDR. The S0 and FDR parameters were set to 0.5 and 0.05, respectively
(Supplementary Data 2 and 3).
Recombinant expression and purification of GST proteins. 50 ng plasmid DNA
were transformed into competent E, coli (BL21). For each construct one clone
(colony) was picked, inoculated (0.1 mg/ml ampicillin) and again incubated (37 °C,
ON) while shaking. Next, pre-culture was inoculated in LB medium and grown
until an OD of 600 nm was reached. The pre-culture was induced by adding 0.3
mM IPTG (Roth) and incubated for 16–18 h (18 °C) while shaking. Following, the
culture was pelleted and shock frozen in liquid nitrogen and resuspended in lysis
buffer (PBS, 0.4 M NaCl, protease inhibitors). After sonication (Branson Sonifier
250-D), cells were centrifuged and the supernatant was mixed with glutathione
sepharose beads (GE healthcare). After immunoprecipitation (2 h, 4 °C), beads
were washed 3 × 5min with wash buffer (PBS, protease inhibitors). For storage
(−80 °C), beads were resuspended in storage buffer (TE, 50 mM NaCl, 10%
glycerol).
Some experiments required eluted protein. Here, GST–protein was purified via
a GST-trap column (GE healthcare) and the Äkta pure system (GE healthcare).
After elution with elution buffer (PBS, 30 mM glutathione (Sigma)), proteins were
dialyzed (4 °C, ON) using a special membrane (MWCO 6-8.000, Spectra/Pore,
(Roth)) in 1 L potassium phosphate buffer (PPB) (150 mM NaCl, 25 mM HEPES
pH 7.6, 2 mM MgCl2, 10% glycerol, 0.1 mM EDTA, 0.05% NP-40). Purified, GST-
tagged proteins were concentrated by using centrifugal filter units (Millipore).
Preparation of S1 mononucleosomes and immunoprecipitation. For each IP, S1
mononucleosomes from 1 × 107 HK cells were prepared as previously described12.
GST-tagged proteins were washed 2× in washing buffer, added to S1 mono-
nucleosomes and incubated (4 °C, ON, rotating). Following immunoprecipitation,
proteins were washed 2× for 10 min in reduced EX-100 I (0.1% NP-40, 10 mM
HEPES pH 7.6, 150 or 300 mM NaCl, 1.5 mM MgCl2, protease inhibitors) and 2 ×
10min in reduced EX-100 II (10 mM HEPES pH 7.6, 150 or 300 mM NaCl,
1.5 mM MgCl2, protease inhibitors) buffers. Proteins were eluted by adding 50 µl
Laemmli Sample Buffer (95 °C, 5 min), loaded onto SDS–PAGE gels and immu-
noblotted (Supplementary Fig. 8). Immunblot detection of proteins was done using
fluorescently labeled secondary antibodies and band intensities quantified using a
LI-COR machine (Bioscience). Analysis was performed by normalization to
H3 signals, with the exception of GST-control precipitations.
Recombinant mononucleosome assembly. Recombinant human H2A, H2A.Z,
H2B, H3, and H4 histones were provided by Hataichanok Scherman (www.
histonesource.com). Totally, 147 and 187-bp DNA fragments (pUC18, gift of
Mueller-Planitz, LMU Munich) were used for mononucleosomes with either 0 or
20 bp linker DNA, respectively. DNA was prepared by PCR using Cy3- or Cy5-
labeled primers (Sigma). Resulting PCR products were polyethyleneglycol- and
isopropanol precipitated and resolved in 1× TE (pH 8). As previously descri-
bed50,51, the assembly of histone octamers and reconstitution of mononucleosomes
was performed by salt-gradient dialysis. Glycerol gradient ultracentrifugation was
applied to enhance the purity of recombinant mononucleosomes. Finally, the
nucleosomal DNA concentration was determined by UV absorption measurement
(260 nm).
Recombinant human TL histone octamers were provided by Hataichanok
Scherman (www.histonesource.com). Ten microlitre reactions were set up
containing 0.85 µg histone octamers and 1 µg DNA in initial dilution buffer
(10 mM HEPES pH 7.9, 1 mM EDTA pH 8, 0.5 mM PMSF) with a final salt
concentration of 2M NaCl and incubated at 37 °C for 15 min. Reactions were
transferred to 30 °C and serial diluted with initial dilution buffer (3.3, 6.7, 5.0, 3.6,
4.7, 6.7, 10, 30, and 20 µl). Fifteen minute incubation step (30 °C) was done after
each dilution. Finally, reaction was diluted in 100 µl final dilution buffer (10 mM
Tris-HCl pH 7.5, 5 mM EDTA pH 8, 20% glycerol, 0.1% NP-40, 5 mM DTT, 0.5
mM PMSF, 100 µg/mL BSA fraction V (Sigma)), again incubated at 30 °C for 15
min and stored at 4 °C.
Competitive electrophoretic mobility shift assay. Depending on the application,
5% (recombinant mononucleosomes) or 8% (nucleic acids) native polyacrylamide
gels (0.2× TBE, x% polyacrylamide, 0.9% APS, 0.1% TEMED) were used and
prerun (1 h, 100 V, ice bath) in running buffer (0.2× TBE).
Recombinant, GST-tagged proteins were diluted to desired concentrations
in PPB buffer (150 mM NaCl, 25 mM HEPES pH 7.6, 2 mM MgCl2, 10% glycerol,
0.1 mM EDTA, 0.05% NP-40). Cy5-labeled R-601 DNA (25 bp) (Eurofins
Genomics) or Cy3-labeled R-601 RNA (25 bp) (Sigma) and recombinant
mononucleosomes (Cy3 or Cy5) were diluted in EMSA binding buffer (TE, 50 mM
NaCl, 10% glycerol, 0.1% BSA, 0.5 mM DTT) to a final concentration of 20 nM and
mixed 1:1 with different protein concentrations and incubated for 25 min on ice
(dark) in a total volume of 15 µl per reaction. Samples were loaded on a native gel
and ran (1 h 45 min, 100 V, dark) on ice and analyzed using a Typhoon FLA9500
(GE Healthcare Life Sciences).
Immunoprecipitation and immunoblotting of MTA1 and MBD3. Nuclear extract
was prepared using a modified version of previously described procedures45,52.
Briefly, cells were resuspended in hypotonic Buffer A (10 mM HEPES-KOH, pH
7.9, 1.5 mM MgCl2, 10 mM KCl) with 0.5 mM dithiothreitol (DTT) and protease
inhibitors and incubated on ice for 15 min. NP-40 was added at final concentration
of 0.6% and cells were vortexed to obtain cell nuclei. After centrifugation of cell
lysate, nuclear pellet was resuspended in Buffer C (420 mM NaCl, 20 mM HEPES-
KOH, pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA) with 0.1% NP-40,
0.5 mM DTT and protease inhibitors. The suspension was incubated with rotation
for 1 h at 4 °C, and then spun at 18,000×g for 20 min at 4 °C. The supernatant was
aliquoted, snap frozen in liquid nitrogen and stored at −80 °C.
For immunoprecipitation, indicated antibodies were incubated with Protein G-
Sepharose beads (Sigma) for 1 h at room temperature (RT). Nuclear extract (200 µg)
was diluted in IP-buffer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 1 mM EDTA, 1%
Triton X-100, 10% glycerol) with protease inhibitors and incubated with antibody-
bead conjugates at 4 °C ON. The beads were then washed three times in low-salt
wash buffer (IP-buffer containing 150mM NaCl), followed by two washes in high-
salt wash buffer (IP-buffer containing 300mM NaCl). Immunoprecipitated proteins
were eluted by boiling in 2× Laemmli sample buffer with DTT.
For Western Blot analysis, proteins were separated by SDS–PAGE and blotted
onto nitrocellulose membrane. The membrane was blocked for 1 h in TBS-T
containing 5% skimmed dry milk and incubated ON at 4 °C with the indicated
antibodies diluted in Blocking Buffer. After washes, membranes were incubated
with HRP-conjugated secondary antibodies diluted in TBST for 1 h at RT. HRP
activity was detected using ECL Western Blotting Detection Reagent (GE
Healthcare).
Binding of recombinant MTA1 and PWWP2A. Suspension-adapted HEK
Expi293FTM cells were grown to a density of 2 × 106 cells/ml. Combinations of
equimolar quantities of plasmids were co-transfected into cells using linear 25-kDa
polyethylenimine (PEI) (Polysciences, Warrington, PA, USA). Six microgram of
DNA mix was first diluted in 324 µL of PBS and vortexed briefly. Twelve micro-
gram of PEI was then added and the mixture was vortexed again, incubated for
20 min at RT, and then added to 3.0 mL of HEK cell culture. The cells were
incubated for 65 h at 37 °C with 5% CO2 and horizontal orbital shaking at 130 rpm.
Totally, 1.5-ml aliquots of cells were then harvested, washed twice with PBS,
centrifuged (300g, 5 min), snap frozen in liquid nitrogen and stored at –80 °C.
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Lysates were prepared by sonicating thawed cell pellets in 0.5 ml of lysis buffer (50
mM Tris-HCl, 500 mM NaCl, 1% (v/v) Triton X-100, 1× cOmplete® EDTA-free
protease inhibitor (Roche, Basel, Switzerland), 0.2 mM DTT, pH 7.9), incubating
on ice for 30 min to precipitate chromatin and then clarifying the lysate via cen-
trifugation (≥16,000g, 20 min, 4 °C). The cleared supernatant was used for FLAG-
affinity pulldowns as described below.
Immunoprecipitation of proteins produced in HEK293 cells. In all, 20 µl of anti-
FLAG Sepharose 4B beads (Bimake, Houston, TX, USA; pre-equilibrated with 50
mM Tris-HCl, 500 mM NaCl, 1% (v/v) Triton X-100, 1× cOmplete® EDTA-free
protease inhibitor (Roche), 0.2 mM DTT, pH 7.9) was added to 0.5 mL of cleared
HEK cell lysate. The mixtures were incubated for 3 h at 4 °C with orbital rotation.
Postincubation, the beads were washed with 3× 1ml “wash” buffer A (50 mM Tris-
HCl, 500 mM NaCl, 0.5% (v/v) IGEPAL® CA630, 0.2 mM DTT, pH 7.5), and 2× 1
ml “wash” buffer B (50 mM Tris-HCl, 150 mM NaCl, 0.5% (v/v) IGEPAL® CA630,
0.2 mM DTT, pH 7.5). Bound proteins were eluted by 3× 20 µl treatment with
“elution” buffer (10 mM HEPES, 150 mM NaCl, 300 µg/ml 3× FLAG peptide
(MDYKDHDGDYKDHDIDYKDDDDK)), pH 7.5 for 1 h at 4 °C. Elution fractions
were pooled for downstream analyses.
SDS–PAGE and immunoblot analysis. Samples of Expi293FTM lysates and anti-
FLAG purification protein elutions were subjected to protein gel electrophoresis
using BoltTM 4–12% Bis–Tris Plus gels (Thermo Fisher Scientific) and run in MES
buffer at 165 V for 50 min. Gels were washed, fixed and stained with SYPRO Ruby
(Thermo Fisher Scientific) according to the manufacturer’s instructions. The gels
were scanned with a Typhoon FLA-9000 laser scanner (473 nm excitation, ≥510
nm emission filter; GE Healthcare, Chicago, IL, USA). For western blot analysis,
the gel-separated proteins were blotted onto PVDF membranes and probed with
appropriate antibodies (Supplementary Fig. 9).
Recombinant production of S_PWWP and NMR spectroscopy. Escherichia coli
Rosetta (DE3) pLysS cells transformed with an S_PWWP encoding plasmid (or
point mutants) were cultured at 37 °C with shaking. Log-phase cultures (OD:
0.4–0.8) were induced by addition of IPTG (0.3 mM), and cultured for a further 18
h at 18 °C with shaking. Cell pellets containing overexpressed protein were lysed by
snap freezing followed by sonication and purified using GSH affinity chromato-
graphy. The N-terminal GST-tag was removed by incubation of GSH elution
fractions with HRV-3C protease (produced in-house) at 4 °C. Fractions were
concentrated in a centrifugal concentrator to 50–200 µM and one-dimensional 1H
NMR spectra recorded on a Bruker 600MHz NMR spectrometer at 25 °C.
Native ChIP-seq (nChIP-seq). Preparation of samples for nChIP-seq was per-
formed as previously described12 with a few adjustments. In brief, S1 mono-
nucleosomes isolated from 5 × 106 HK cells subjected to PWWP2A or control
siRNAs were used per nChIP. Fifteen microlitre magnetic Dynabeads Protein G
(Thermo Fisher) were precoupled for 2.5 h with either 2 µg anti-H3K27ac or anti-
H2A.Zac and incubated with mononucleosomes ON. Beads-only IP served as
negative control. Beads were washed twice with WB1 (10 mM Tris pH 7.5, 1 mM
EDTA, 0.1% SDS, 0,1% sodiumdeoxycholate, 1% TritonX-100), twice with WB2
(150 mM NaCl, 10 mM Tris pH 7.5, 1 mM EDTA, 0.1% SDS, 0.1% sodiumdeox-
ycholate, 1% Triton X-100), once with TE+ 0.2% Triton-X and once with TE
buffers. Washed beads were resuspended in 100 µl TE, 3 µl 10% SDS and 5 µl of 20
mg/ml proteinase K and incubated for 1 h at 65 °C. Suspensions were vortexed
briefly, magnetically separated and the supernatant transferred to a fresh tube.
Beads were washed once with 100 µl TE containing 0.5 M NaCl, magnetically
separated and the supernatant mixed with the first supernatant. Input fractions
were processed in parallel. After Phenol/chlorophorm/isoamylalcohol extraction
and ethanol precipitation, the DNA pellet after IP was resuspended in 12 µl and the
input DNA pellet in 32 µl 10 mM Tris-HCl (pH 7.5). DNA concentrations were
determined with the Qubit dsDNA HS Kit (Invitrogen) and DNA size monitored
on a 1000 DNA BioAnalyzer chip (Agilent). Illumina Sequencing libraries were
established with the MicroPlex Library Preparation Kit (Diagenode) following the
manufacturer’s instructions. The number of amplification cycles was scaled
according to the amount of input material and amplification was validated by
determination of DNA concentrations using the Qubit dsDNA HS Kit (Invitrogen).
Quality of purified libraries were assessed using a 1000 DNA BioAnalyzer chip
(Agilent) . Sequencing was performed on the Illumina 1500 platform using the
TruSeq Rapid SR Cluster Kit-HS (Illumina) and single read 50 nucleotide
sequencing on a HiSeq Rapid SR Flow Cell (Illumina).
Image analysis and base calling were performed using the Illumina pipeline v
1.8 (Illumina Inc.). Raw and processed data have been deposited in the NCBI gene
expression omnibus (GEO) under accession number GSE110222.
Public data sets analyzed. H3K4me3, PWWP2A, H2A.Z.1 and H2A.Z.2 data
from HeLa Kyoto cells were used as previously deposited at GEO (GSE78009).
ChIP-seq data for additional histone modifications were downloaded from the
ENCODE portal at UCSC (http://hgdownload.soe.ucsc.edu/goldenPath/hg19/
encodeDCC/wgEncodeBroadHistone/).
H4K4me1: wgEncodeBroadHistoneHelas3H3k04me1StdRawDataRep1.fastq.gz;
H3K4me3: wgEncodeBroadHistoneHelas3H3k4me3StdRawDataRep1.fastq.gz;
H3K27ac: wgEncodeBroadHistoneHelas3H3k27acStdAlnRep1.fastq.gz;
H3K27me3: wgEncodeBroadHistoneHelas3H3k27me3StdRawDataRep1.fastq.gz;
H3K36me3: wgEncodeBroadHistoneHelas3H3k36me3StdRawDataRep1.fastq.gz.
Raw sequencing reads were mapped to the human genome (hg19) using bowtie
(1.1.2) with parameters –k and –m set as 153. PCR duplicates were removed with
samtools rmdup function. Coverage vectors were generated after read extension to
150 bp corresponding to the expected fragment size after MNase digestion using
Deeptools bamCoverage function normalizing to 1× sequencing depth
(–normalizeTo1× option)54. Peak calling was done using MACS2 version 2.1.155
with default settings. Cumulative coverage plots and heatmaps were generated with
deeptools computeMatrix and plotHeatmap functions. In order to generate the
Venn diagram in Supplementary Fig. 6a, we included normalized (using DESeq2
method) read counts introducing an additional criterion beyond overlap of
detected peak intervals in order to increase stringency. In case of absence of an
overlap for a given peak interval, we asked to have at least a twofold enrichment in
normalized read counts of the binding factor over the presumptive nonbinding
factor (as described in ref. 56). Thereby we substantially reduced the large number
of incidences, were comparison of peak calling results in detection of binding
events seemingly unique for one factor, where there actually is substantial binding
detected in case of the other factor, too, but the peak calling process just failed to
include it in the final peak list. As gene models, we used UCSC hg19 gene models
downloaded from Illumina’s iGenome repository. For collection of binding data
around meta-genes, 6 kb upstream and downstream regions were collected as 50-
bp bins and gene bodies were represented by 120 bins of variable size. K36me3-rich
gene bodies were identified by collecting. Differential binding analysis was done
using csaw57, and validated by a custom analysis pipeline. For csaw we binned the
human genome into 100 bp bins with a step size of 300 bp. Normalization was
performed by extraction of scaling factors based on 10 kb bins basically
normalizing for total read count. Differentially regulated bins were selected as those
bins with a p value < 0.001. For representation of significantly changed regions in
heatmaps we merged neighboring significantly changed bins by a sliding window
approach (width: 2 kb). In an alternative approach, we calculated the peaks
overlapping between control treatments as well as those overlapping between RNAi
treatments. Peaks were combined and overlapping peaks were merged into single
features spanning the original features’ intervals. Read counts overlapping these
intervals were determined for the four experimental conditions (untreated, Luci
siRNA, PWWP2A siRNA 1 and 2) and DESeq2 was used for normalization as well
as for the identification of differentially bound peak intervals58.
In general, we found good agreement between both methods and in the
heatmap in Fig. 6a we used those genomic regions as reference point, that were
detected by both algorithms.
Chromatin states. In order to assign chromatin states, we used publicly available
H3K4me1/3, H3K27ac, H3K27me3, and H3K36me3 data from HeLa cells gener-
ated by the ENCODE consortium59. We discretized the human genome into 1 kb
bins and trained a 10-state HMM using the ChromHMM application using default
parameters60. In order to calculate the ratio between observed and expected overlap
we calculated the overlap between PWW2PA and H2A.Z.1 peaks and the set of
intervals associated with the respective chromatin state. This was divided by the
sum of all PWWP2A (or H2A.Z.1) peak interval widths in order to calculate the
observed overlap. The expected overlap was calculated as the ratio between the sum
of the interval widths of the respective chromatin state and the total genome size.
Plotting and statistics. All downstream analysis was done in R/BioConductor61.
Genome browser snap shots were generated using the Gviz package62. Manip-
ulation of sequencing reads was done using Rsamtools63 and genomic intervals
were represented as GenomicRanges objects64. The analysis of the association
between peak intervals and known genomic annotation feature were done using the
ChIPseeker package65 with default setting using the UCSC hg19 gene definitions
(BioConductor package TxDb.Hsapiens.UCSC.hg19.knownGene). As statistical
tests, we performed Wilcoxon rank sum tests. The code underlying our analysis is
available upon request.
nChIP-qPCR. QPCR was performed on a LightCycler® 480 Instrument II (Roche)
using Fast SYBR Green Master Mix (Applied Biolabs). PCR efficiency and primer
pair specificity was examined using a standard curve of serially diluted DNA and
melting curve, respectively. Data were analyzed according to the percent input
method. The following primer sets were used:
CCL5 TSS:
F: 5′ ATTTCTCTGCTGACATCCTTAGT 3′
R: 5′ TCCTAACTGCCACTCCTTGT 3′
CCL5 remote:
F: 5′ GGATCCCAAGAGAAGCCTGA 3′
R: 5′ CAGGGGCAAAGAAGGAGAGA 3′
FST close:
F: 5′ TGCCATCCTTAGACCTCAGA 3′
R: 5′ AGCACTGCCAGGACTACATT 3′
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ZNF19 remote:
F: 5′ CACACAAAACATTTCTCCATCAGG 3′
R: 5′ AGGTTTTCTTGCCTTGGAACA 3′
B3GALNT2 remote:
F: 5′ TGTCTCCCTGAAACTCATCTCT 3′
R: 5′ GCACTAATCCTGCCTTCCTG 3′
CCDC71 TSS:
F: 5′ GTGGTGCATTGACATCTGGG 3′
R: 5′ CTGGGACTGAAGTGGGCATT 3′
RNA isolation, cDNA preparation, and RT-qPCR. Samples for RNA isolation
were harvested concurrent with samples for nChIP. Total RNA from HeLa Kyoto
cells untreated, subjected to control siRNA (Luci) or PWWP2A siRNAs was iso-
lated using the RNeasy Mini Kit (Qiagen) according the manufacturer’s instruc-
tions. One microgram of total RNA was reverse transcribed utilizing the NEB
ProtoScript M-MuLV First Strand cDNA Synthesis Kit (NEB) according the
manufacturer’s instructions. QPCR was performed on a LightCycler® 480 Instru-
ment II (Roche) using Fast SYBR Green Master Mix (Applied Biolabs). PCR
efficiency and primer pair specificity was examined using a standard curve of
serially diluted cDNA and melting curve, respectively. After normalization to the
transcript level of HPRT1 (hypoxanthine phosphoribosyltransferase 1), data were
analyzed based on the 2−ΔΔCT method. For incorporating the standard error of
the mean of the ΔΔCT values into the fold-difference, we calculated the range
of the error bars as 2(–ΔΔCt+ SEM) and 2(–ΔΔCt - SEM). The following primer sets
were used:
CCL5:
F: 5′ CTCGCTGTCATCCTCATTGC 3′
R: 5′ TACTCCTTGATGTGGGCACG 3′
FST:
F: 5′ TGCCTGCCACCTGAGAAAG 3′
R: 5′ TCTCCCAACCTTGAAATCCCA 3′
ZNF19:
F: 5′ CCCAGCAGAGAGGACCAAAA 3′
R: 5′ GCTGACCATGTGACATCATCC 3′
B3GALNT2:
F: 5′ TGGCTGCCATAGGACCTAA 3′
R: 5′ TCCACAGTTCCGTCAGTTCC 3′
CCDC71:
F: 5′ AAAGCTGCTGAAGTTCCGTG 3′
R: 5′ TGGAGCCGTATTACAGGTGA 3′
Data availability
The nChIP-seq data analyzed in this publication have been deposited in NCBI’s Gene
Expression Omnibus66 and are accessible through GEO Series accession number
GSE110222. [GSE110222]. The mass spectrometry proteomics data sets have been
deposited to the ProteomeXchange Consortium via the PRIDE67 partner repository with
the dataset identifiers PXD010202 [PXD010202] for GFP–PWWP2A IPs, and
PXD010424 [PXD010424] for histone PTMs.
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